kynurenine has been researched along with B16 Melanoma in 3 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Grobben, Y | 1 |
| de Man, J | 1 |
| van Doornmalen, AM | 1 |
| Muller, M | 1 |
| Willemsen-Seegers, N | 1 |
| Vu-Pham, D | 1 |
| Mulder, WR | 1 |
| Prinsen, MBW | 1 |
| de Wit, J | 1 |
| Sterrenburg, JG | 1 |
| van Cauter, F | 1 |
| den Ouden, JE | 1 |
| van Altena, AM | 1 |
| Massuger, LF | 1 |
| Uitdehaag, JCM | 1 |
| Buijsman, RC | 1 |
| Zaman, GJR | 1 |
| Meng, X | 1 |
| Du, G | 1 |
| Ye, L | 1 |
| Sun, S | 1 |
| Liu, Q | 1 |
| Wang, H | 1 |
| Wang, W | 1 |
| Wu, Z | 1 |
| Tian, J | 1 |
| Liu, Y | 1 |
| Lv, J | 1 |
| Liu, J | 1 |
| Liang, X | 1 |
| Jin, X | 1 |
| Xie, J | 1 |
| Zhang, L | 1 |
| Chen, D | 1 |
| Fiskesund, R | 1 |
| Tang, K | 1 |
| Ma, J | 1 |
| Zhang, H | 2 |
| Dong, W | 1 |
| Mo, S | 1 |
| Zhang, T | 1 |
| Cheng, F | 1 |
| Zhou, Y | 1 |
| Jia, Q | 1 |
| Zhu, B | 1 |
| Kong, Y | 1 |
| Guo, J | 1 |
| Hu, ZW | 1 |
| Cao, X | 1 |
| Qin, FX | 1 |
| Huang, B | 1 |
3 other studies available for kynurenine and B16 Melanoma
| Article | Year |
|---|---|
Targeting Indoleamine 2,3-Dioxygenase in Cancer Models Using the Novel Small Molecule Inhibitor NTRC 3883-0.
Topics: Animals; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cell Proliferation; Humans; Indoleamine-Pyrro | 2020 |
Combinatorial antitumor effects of indoleamine 2,3-dioxygenase inhibitor NLG919 and paclitaxel in a murine B16-F10 melanoma model.
Topics: Animals; Antineoplastic Agents; Drug Therapy, Combination; Imidazoles; Indoleamine-Pyrrole 2,3,-Diox | 2017 |
STAT3/p53 pathway activation disrupts IFN-β-induced dormancy in tumor-repopulating cells.
Topics: Active Transport, Cell Nucleus; Animals; Cell Line, Tumor; Female; HEK293 Cells; Humans; Immune Syst | 2018 |